Companies: 10,795·Total market cap: $144.5T
Masimo Corporation

Masimo Corporation

MASINASDAQHealthcare● Active
$179.94
+$1.12(+0.63%)
Market Cap$9.4B
P/E Ratio
52W High$179.955
52W Low$125.94

Masimo Corporation (MASI) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MASI · cash on hand · updated Jan 3, 2026

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$152.3M -14.2% vs prior year
FY · as of Jan 3, 2026 · Reported in USD
Cash & Cash Equiv. (CCE)
$152.3M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-14.2%
vs prior fiscal year
Latest Quarter
$124.6M
Q2 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: January 3, 2026

Net cash vs debt

Cash & ST Investments$152.3MCash on Hand
Total Debt$559.3MTotal Debt
Net Cash / Net Debt−$407.0MNet Debt Position
Cash vs Debt Ratio
Cash 21%Debt 79%

Masimo Corporation carries a net debt position of $407.0M. Total debt ($559.3M) exceeds cash on hand ($152.3M). Masimo Corporation cash vs debt ratio: 21% cash / 79% debt.

Net Cash = Cash & ST Investments − Total Debt$152.3M$559.3M = −$407.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MASI annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jan 3, 2026Latest$152.3M-14.2%
Dec 28, 2024$177.6M+9.0%
Dec 31, 2023$163.0M-19.7%
Dec 31, 2022$202.9M-72.8%
Dec 31, 2021$745.3M+16.2%
MASI cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Masimo Corporation
Masimo CorporationYOU
MASI
$152.3M1.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Masimo Corporation (MASI) cash on hand as of January 3, 2026 is $152.3M, comprising $152.3M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Masimo Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Masimo Corporation cash reserves or cash position.

Masimo Corporation annual cash on hand history shows decreased -14.2% in 2026: decreased -14.2% in 2026. Masimo Corporation cash reserves in 2026 reflect the company's capital allocation strategy.

Masimo Corporation carries total debt of $559.3M against cash of $152.3M, resulting in a net debt position of -$407.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

MASI cash on hand · 5 questions

As of January 3, 2026, Masimo Corporation (MASI) has $152,300,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $152,300,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (April 4, 2026): $124,600,000. Data sourced from the annual 10-K filing via FMP.

MASI cash on handMASI cash reservesMASI cash 2026how much cash does MASI have

Source: FMP /balance-sheet-statement · US GAAP · Masimo Corporation · Masimo Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: January 3, 2026